| Ashley Glock, MD | |
|
400 N Erie Hwy Ste A, Hamilton, OH 45011-4264 | |
| (513) 887-3710 | |
| Not Available |
| Full Name | Ashley Glock |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 400 N Erie Hwy Ste A, Hamilton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275993933 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | COND. 2016166 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Glock, MD 433 Parkview Ct, Monroe, OH 45050-2112 Ph: (513) 212-3333 | Ashley Glock, MD 400 N Erie Hwy Ste A, Hamilton, OH 45011-4264 Ph: (513) 887-3710 |
News Archive
A study conducted at Johns Hopkins University School of Medicine in Baltimore has revealed distinct differences in the immune pathways that are activated by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and those that are activated by influenza.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
Clinical depression can exacerbate the symptoms of knee arthritis beyond what is evident on X-rays, according to a new study from the Journal of Bone and Joint Surgery.
Red blood cell prion filtration does not increase the risk for alloimmunization or transfusion reactions, suggest results from the largest safety study to date.
Sun Pharma today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the judgment of the U.S. District Court for the Eastern District of Michigan against Eli Lily and Co. finding certain claims of U.S. Patent No. 5,464,826 ("'826 patent") invalid. The appeal arose out of a lawsuit that Eli Lilly filed against Sun Pharma in connection with Sun Pharma's submission of an Abbreviated New Drug Application (ANDA) for a generic version of Gemzar®.
› Verified 5 days ago
Kelly Taylor, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3980 Hamilton Cleves Rd, Hamilton, OH 45013 Phone: 513-738-1972 | |
Mrs. Kristina Bunger, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 533 Dayton St, Hamilton, OH 45011 Phone: 513-887-5000 | |
Morgan L Murray, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 N Erie Hwy, Hamilton, OH 45011 Phone: 513-887-3710 | |
Melissa Ann Sancrant, MED. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1302 Millville Ave, Hamilton, OH 45013 Phone: 513-867-4100 | |
Eskarsy Canales, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Seven Mile Ave, Hamilton, OH 45011 Phone: 513-863-0833 | |
Cindy Cullen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 N Erie Hwy, Hamilton, OH 45011 Phone: 513-887-3710 | |
Jill Suzanne Joseph, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4380 Eaton Rd, Hamilton, OH 45013 Phone: 513-518-4552 |